Bone marrow fibrosis during therapy of hairy cell leukemia

Dĕdic, K.; Zák, P.

Ceskoslovenska Patologie 40(1): 22-24

2004


ISSN/ISBN: 1210-7875
PMID: 15035057
Document Number: 568356
The influence of Cladribin therapy to bone marrow fibrosis in patients with hairy cell leukemia was studied. Eighteen patients were included in the study; bone marrow fibrosis was graded 0-4 according to the quantity and pattern of distribution of reticulin. The grade of bone marrow fibrosis was established before the therapy and then in 12- and 24-month intervals. Patients showed complete remission after the therapy and remarkable reduction of bone marrow fibrosis.

Document emailed within 1 workday
Secure & encrypted payments